Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

There is a good article on Seeking Alpha about EXEL yesterday highlighting how EXEL is following DNDN into bankruptcy. I bring this to your attention because Ariad has some of the same characteristics as EXEL (one approved cancer treatment product, minimal sales below expectations, huge management structure -ariad's 21 Vice Presidents, recent large convertible debt offering, little respect in the investment community, head strong CEO, huge quartet cash burn). I'm not saying Ariad is going bankrupt at this time, but you better pay close attention as we move forward.